SynthesisThe Lancet. Public health2021
Prevalence of electronic nicotine delivery systems and electronic non-nicotine delivery systems in children and adolescents: a systematic review and meta-analysis.
Synthesis in The Lancet. Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
39 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- The association between self-reported vaping and the human oral microbiome: a systematic review.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026Pooled it
- Interventions to prevent or cease electronic cigarette use in children and adolescents.The Cochrane database of systematic reviews · 2026Pooled it
- The impacts of e-cigarette flavours: An overview of systematic reviews.Addiction (Abingdon, England) · 2025Pooled it
- Interventions to prevent or cease electronic cigarette use in children and adolescents.The Cochrane database of systematic reviews · 2023Pooled it
- A systematic review for the impacts of global approaches to regulating electronic nicotine products.Journal of global health · 2023Pooled it
- Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence.The Medical journal of Australia · 2023Pooled it
- Association Between E-Cigarette Use (Vaping) and Oral Health in Adolescents and Young Adults: A Systematic Review.Journal of clinical medicine · 2026Review
- Study protocol for the Breathe Easy All Together e-cigarette prevention program: a RE-AIM framework-based experimental process and impact evaluation.BMC public health · 2026Article
- Prevalence and Factors Associated with E-cigarettes and Heated Tobacco Products Use among Vietnamese Adolescents.Journal of community health · 2026Article
- Healthcare professionals' roles, perceptions, and interventions relating to e-cigarette and vaping practices: a scoping review.BMC public health · 2026Article
- Cigarette, e-cigarette and dual use among Malaysian adolescents: A secondary analysis of the 2017 and 2022 adolescent health surveys.Tobacco induced diseases · 2026Article
- Vaping and mental health: A cross-sectional study among university students in Bangladesh.PloS one · 2026Article
- Cardiac Autonomic Dysfunction and Increased Oxidative Stress in Conventional Cigarettes and E-Cigarettes: Heart Rate Variability as a Cardiovascular Predictor.Antioxidants (Basel, Switzerland) · 2025Review
- Smoking and vaping in prevocational schools: qualitative insights to support the development of effective prevention strategies.BMC public health · 2025Article
- E-cigarette Attitude and Belief Scale in Adolescents: A Validity and Reliability Study.Thoracic research and practice · 2025Article
- E-cigarette use and susceptibility among Indonesian youth: the role of social environment, social media, and individual factors.BMC public health · 2025Article
- Article
- What Strategies Do Healthcare Providers Use to Promote Adolescents' Vaping Cessation? A Scoping Review.International journal of environmental research and public health · 2025Article
- Article
- Biomarkers of Toxicant Exposure among Youth in Canada, England, and the United States Who Vape and/or Smoke Tobacco or Do Neither.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
backgroundThere are concerns that the use of electronic nicotine delivery systems (ENDS) and electronic non-nicotine delivery systems (ENNDS) in children and adolescents could potentially be harmful to health. Understanding the extent of use of these devices is crucial to informing public health policy. We aimed to synthesise the prevalence of ENDS or ENNDS use in children and adolescents younger than 20 years.
methodsIn this systematic review and meta-analysis, we undertook an electronic search in five databases (MEDLINE, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Embase, and Wiley Cochrane Library) from Jan 1, 2016, to Aug 31, 2020, and a grey literature search. Included studies reported on the prevalence of ENDS or ENNDS use in nationally representative samples in populations younger than 20 years and collected data between the years 2016 and 2020. Studies were excluded if they were done in those aged 20 years or older, used data from specialist panels that did not apply appropriate weighting, or did not use methods that ensured recruitment of a nationally representative sample. We included the most recent data for each country. We combined multiple national estimates for a country if they were done in the same year. We undertook risk of bias assessment for all surveys included in the review using the Joanna Briggs Institute Critical Appraisal Checklist (by two reviewers in the author list). A random effects meta-analysis was used to pool overall prevalence estimates for ever, current, occasional, and daily use. This study was prospectively registered with PROSPERO, CRD42020199485.
findingsThe most recent prevalence data from 26 national surveys representing 69 countries and territories, with a median sample size of 3925 (IQR 1=2266, IQR 3=10 593) children and adolescents was included. In children and adolescents aged between 8 years and younger than 20 years, the pooled prevalence for ever (defined as any lifetime use) ENDS or ENNDS use was 17·2% (95% CI 15-20, I
interpretationThere is significant variability in the prevalence of ENDS and ENNDS use in children and adolescents globally by country income status. These findings are possibly due to differences in regulatory context, market availability, and differences in surveillance systems.
fundingWorld Health Organization and the Bill & Melinda Gates Foundation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.